Jin Bu Huan
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Health Affairs issues March 18 memorandum to agency field offices outlining the potential health risks associated with Jin Bu Huan and asking field officers to report where the herbal product is sold. The memo was sent out to gauge how widely available the herbal product is so that FDA can determine what type of action is necessary. To date, Jin Bu Huan has been located in Los Angeles, San Francisco, Minneapolis/St. Paul and Denver, FDA said. The California health department recently issued a warning on the risk of hepatitis associated with Jin Bu Huan ("The Tan Sheet" March 28, p. 27)